Eagle Pharmaceuticals, Inc. to Discuss Second Quarter 2017 Financial Results on August 9, 2017
July 31 2017 - 6:50AM
Business Wire
Eagle Pharmaceuticals, Inc. ("Eagle" or “the Company”)
(Nasdaq:EGRX) announced today that the Company will release its
2017 second quarter financial results on Wednesday, August 9, 2017,
before the market opens.
Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief
Financial Officer, will host a conference call to discuss the
results as follows:
Date Wednesday, August 9, 2017 Time 8:30 a.m.
EDT Toll free (U.S.) 888-632-3382 International 785-424-1677
Webcast (live and replay)
www.eagleus.com, under the “Investor
Relations” section
A replay of the conference call will be available for one week
after the call's completion by dialing 800-388-6197 (US) or
402-220-1115 (International) and entering conference call ID
EGRXQ217. The webcast will be archived for 30 days at the
aforementioned URL.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on
developing and commercializing injectable products that address the
shortcomings, as identified by physicians, pharmacists and other
stakeholders, of existing commercially successful injectable
products. Eagle’s strategy is to utilize the FDA's 505(b)(2)
regulatory pathway. Additional information is available on the
company’s website at www.eagleus.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170731005256/en/
Investor Relations for Eagle Pharmaceuticals, Inc:Lisa M.
Wilson, 212-452-2793lwilson@insitecony.com
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Sep 2023 to Sep 2024